PharmAla Biotech Says Received Guidance on ALA-002 From MHRA; Launching Clinical Program With University of Sydney
PharmAla Biotech Says Received Guidance on ALA-002 From MHRA; Launching Clinical Program With University of Sydney
PharmaLa Biotech 表示已獲得 MHRA 關於 ALA-002 的指導；與悉尼大學合作啓動臨床項目
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊